dAVP [2745]
dAVP
| SMILES | N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCCC(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |
| InChIKey | NFLWUMRGJYTJIN-UHFFFAOYSA-N |
| Sequence | XYFQNCPRG |
| HELM | PEPTIDE1{[*C(=O)CCS* |$_R2;;;;;;_R3$|].(Y,[dY]).(F,[dF]).(Q,[dQ]).(N,[dN]).(C,[dC]).(P,[dP]).(R,[dR]).G.[am]}$PEPTIDE1,PEPTIDE1,1:R3-6:R3$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
No bioactivity data available.
dAVP
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0